author-photo

Elisabeth Heath

Nereus Pharmaceuticals

2

Papers

2

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Phase 1 clinical trials of NPI-2358 (a novel vascular disrupting agent) in patients with solid tumors and lymphomas

2007 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (2)